Close Button Icon
Doptelet avatrombopag Tablets Logo

You are about to leave DOPTELET.com/itp and go to an external page.

Please note that Sobi, Inc. is not responsible for the content of the website you are
about to visit.

CONTINUE

Go back

Close Modal

Discover the Doptelet Copay
Assistance Program

Eligible commercially insured patients may qualify for the Doptelet Copay Assistance Program

What's the program?

  • Eligible patients may pay as little as $0 for each Doptelet prescription
  • Annual maximum benefit up to $15,000

Eligible patients must:

  • Have commercial insurance that covers Doptelet
  • Not be enrolled in any state or federal healthcare program such as Medicare, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DOD), or TRICARE
  • Be 18 years of age or older
  • Be a resident in the United States or a US Territory

How to enroll:

  • Approved pharmacies, healthcare professionals, and Doptelet Connect can enroll patients
  • Patients can enroll themselves as well as their caregivers
  • Please call 1-833-368-2663 Monday–Friday 8am–8pm ET for more information

Terms and Conditions

  • Patients pay as little as $0 per prescription. Copay Assistance Program has an annual calendar cap of $15,000
  • The Copay Assistance Program is void where prohibited by law, taxes, or restricted
  • This offer is non-transferable, no substitutions are permissible, and this offer cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription
  • Sobi, Inc. reserves the right to rescind, revoke, or amend this offer at any time without notice
  • The Copay Assistance Program for Doptelet is not insurance and is not intended to substitute for insurance
  • Patients, pharmacists, and healthcare providers must not seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this Copay Assistance Program. Patients must not seek reimbursement from any health savings, flexible spending, or other healthcare reimbursement accounts for the amount of assistance received from the Copay Assistance Program
  • Certain information pertaining to your use of the Copay Assistance Program will be shared with Sobi, Inc., the sponsor of the Copay Assistance Program. The information disclosed will include the date the prescription is filled, the number of pills or product dispensed by the pharmacists, and the amount of your copay that will be paid for by using this Copay Assistance Program. For more information, please see the Sobi Privacy Policy at https://sobi-northamerica.com/privacy-policy
  • Acceptance in this Copay Assistance Program is not conditioned on any past, present, or future purchase, including additional doses
  • Enrollment for the Copay Assistance Program is valid through the calendar year
  • Sobi reserves the right to change program terms at any time
  • What Is Chronic ITP?
    • Signs & Symptoms
    • Treating Chronic ITP
  • Setting Goals
  • About Doptelet
  • Patient Stories
  • Chronic ITP Resources
    • Patient Resources
    • Financial Assistance Information
    • Get ITP Tips
    • FAQs
  • GET ITP TIPS
  • Doptelet for Chronic Liver Disease
  • Prescribing Information
  • Healthcare Professional Site
  • Doptelet Blue FaceBook Icon
  • Doptelet Blue YouTube Icon
  • Doptelet Blue Instagram Icon
Doptelet avatrombopag Tablets Logo
  • What Is Chronic ITP?
    • Signs & Symptoms
    • Treating Chronic ITP
  • Setting Goals
  • About Doptelet
  • Patient Stories
  • Chronic ITP Resources
    • Patient Resources
    • Financial Assistance Information
    • Get ITP Tips
    • FAQs
  • GET ITP TIPS
GET ITP TIPS
Menu
Close
Get the Guide
Close Button Icon

Sobi is providing this free tool to help you find healthcare providers in your area who may have experience treating chronic ITP. Neither Sobi nor MediFind pay healthcare providers to be listed in this tool and healthcare providers do not pay to be listed in the tool. Just because a healthcare provider is listed in the tool does not mean Sobi endorses their qualifications or recommends their medical care. The search results of healthcare providers are sorted by the distance from the location entered. Choosing a healthcare provider is an important decision requiring careful consideration. Sobi is not responsible for your choice or actions you take because of information provided by the tool.

Get Tips for Living With ITP

Sign up for tools and tips to help you manage your chronic ITP, set treatment goals, and have more productive doctor’s visits—plus a few other surprises!

Doptelet Platelet Character Eating Two Ice Cream Cones

NICE!

You’ve successfully signed up—look out for chronic ITP tools and tips flowing your way!

A couple of plateys walking

KEEP LEARNING

About Doptelet
MORE ITP RESOURCES
  • Doptelet Blue FaceBook Icon
  • Doptelet Blue YouTube Icon
  • Doptelet Blue Instagram Icon

Indication & Important Safety Information

What is DOPTELET (avatrombopag)?

Doptelet is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if Doptelet is safe or works in children.

Who should not receive Doptelet?

You should not receive Doptelet if you have ever had a blood clot. You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after taking Doptelet. They can be life-threatening or cause death.

  • You Should Know:
    • Signs and symptoms of a blood clot could include:
      • Swelling, pain, or tenderness in your legs
      • Shortness of breath
      • Chest pain
      • Fast heartbeat
      • Stomach pain or tenderness

Tell your healthcare provider if you are pregnant or breastfeeding, or plan to be while taking Doptelet. It is not known if Doptelet may have unintended side effects for your unborn baby or if Doptelet passes into breast milk. Do not breastfeed while taking Doptelet and for at least 2 weeks after the last dose.

Before taking Doptelet, you should tell your healthcare provider about all your medical conditions and medicines including vitamins, supplements, and herbal remedies.

What are the possible side effects of Doptelet?

For patients with chronic ITP, the most common side effects are headache, fatigue, bruising, nosebleeds, upper respiratory tract infection, joint pain, bleeding gums, purple or red spots on your skin (petechiae), and runny nose.

You Should Know: These are not all of the possible side effects of Doptelet. For more information, ask your healthcare provider or review the Prescribing Information at https://www.doptelet.com/doptelet.pdf.

If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.

For further information, please see full Prescribing Information, including the Patient Information Leaflet.

Sobi Rare Strength Logo
Terms of Use
Privacy Policy
Contact Us
Doptelet Blue FaceBook Icon
Doptelet Blue YouTube Icon
Doptelet Blue Instagram Icon

Doptelet is a registered trademark of AkaRx, Inc., a Sobi company.
Sobi is a registered trademark of Swedish Orphan Biovitrum AB (publ)
Doptelet Connect is a trademark of AkaRx, Inc.
© 2025 Sobi, Inc. – All rights reserved.

PP-15654 v5.0 03/25
For US Residents Only

avatrombopag-tpo-rathank yourecruit thank you
Indication & Important Safety Information
Open ISI Button
Close ISI Button

What is DOPTELET® (avatrombopag)?

Doptelet is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if Doptelet is safe or works in children.

Who should not receive Doptelet?

You should not receive Doptelet if you have ever had a blood clot. You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after taking Doptelet. They can be life-threatening or cause death.

  • You Should Know:

What is DOPTELET (avatrombopag)?

Doptelet is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if Doptelet is safe or works in children.

Who should not receive Doptelet?

You should not receive Doptelet if you have ever had a blood clot. You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after taking Doptelet. They can be life-threatening or cause death.

  • You Should Know:
    • Signs and symptoms of a blood clot could include:
      • Swelling, pain, or tenderness in your legs
      • Shortness of breath
      • Chest pain
      • Fast heartbeat
      • Stomach pain or tenderness

Tell your healthcare provider if you are pregnant or breastfeeding, or plan to be while taking Doptelet. It is not known if Doptelet may have unintended side effects for your unborn baby or if Doptelet passes into breast milk. Do not breastfeed while taking Doptelet and for at least 2 weeks after the last dose.

Before taking Doptelet, you should tell your healthcare provider about all your medical conditions and medicines including vitamins, supplements, and herbal remedies.

What are the possible side effects of Doptelet?

For patients with chronic ITP, the most common side effects are headache, fatigue, bruising, nosebleeds, upper respiratory tract infection, joint pain, bleeding gums, purple or red spots on your skin (petechiae), and runny nose.

You Should Know: These are not all of the possible side effects of Doptelet. For more information, ask your healthcare provider or review the Prescribing Information at https://www.doptelet.com/doptelet.pdf.

If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.

For further information, please see full Prescribing Information, including the Patient Information Leaflet.

Scroll To Top Button

This website uses cookies. By continuing to
use this website, you consent to our use of these cookies. Read more about our use of cookies

SMS Terms link